Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Garcia-Duran

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 21, 2022
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiationCarmen Garcia-Duran, Francisco Grau, Guillermo Villacampa, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Advances in immunotherapy in cervical cancerJuan-Francisco Grau, Lorena Farinas-Madrid, Carmen Garcia-Duran, et al.
Therapeutic Advances in Medical Oncology|April 3, 2023
Advances in immunotherapy for cervical cancerJuan Francisco Grau-Bejar, Carmen Garcia-Duran, David Garcia-Illescas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2024
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical CancerAna Oaknin, Sharad A Ghamande, Yuka Kasamatsu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 12, 2026
Morphological and molecular characterization of epithelial ovarian cancer: SEOM-SEAP consensus guidelines for biomarker integration in clinical practiceGabriel Matheu, María José Bermejo-Peréz, Nuria Escudero-García, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III TrialPhilipp Harter, Frederik Marmé, Andrés Redondo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2026
Evolving landscape of targeted therapies in early phase clinical trialsAlice Rossi, Irene Braña, Maria Vieito, et al.
NPJ Precision Oncology|July 11, 2026
Comprehensive clinical cancer analysis of homologous recombination deficiency biomarkers in an academic molecular profiling programHeura Domènech, Sara Simonetti, Paula Romero-Lozano, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 21, 2022
ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiationCarmen Garcia-Duran, Francisco Grau, Guillermo Villacampa, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 6, 2023
Advances in immunotherapy in cervical cancerJuan-Francisco Grau, Lorena Farinas-Madrid, Carmen Garcia-Duran, et al.
Therapeutic Advances in Medical Oncology|April 3, 2023
Advances in immunotherapy for cervical cancerJuan Francisco Grau-Bejar, Carmen Garcia-Duran, David Garcia-Illescas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2024
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical CancerAna Oaknin, Sharad A Ghamande, Yuka Kasamatsu, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 12, 2026
Morphological and molecular characterization of epithelial ovarian cancer: SEOM-SEAP consensus guidelines for biomarker integration in clinical practiceGabriel Matheu, María José Bermejo-Peréz, Nuria Escudero-García, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III TrialPhilipp Harter, Frederik Marmé, Andrés Redondo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2026
Evolving landscape of targeted therapies in early phase clinical trialsAlice Rossi, Irene Braña, Maria Vieito, et al.
NPJ Precision Oncology|July 11, 2026
Comprehensive clinical cancer analysis of homologous recombination deficiency biomarkers in an academic molecular profiling programHeura Domènech, Sara Simonetti, Paula Romero-Lozano, et al.
Pageof 1